Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tox4 regulates transcriptional elongation and reinitiation during murine T cell development. | Commun Biol | 2023 | 37286708 | PubTator, text mining | PubMed |
| The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer. | Front Immunol | 2023 | 37275913 | PubTator, text mining | PubMed |
| Modulation of T cell function and survival by the tumor microenvironment. | Front Cell Dev Biol | 2023 | 37274739 | PubTator, text mining | PubMed |
| Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells. | J Immunother Cancer | 2023 | 37270181 | PubTator, text mining | PubMed |
| Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications. | Biomark Res | 2023 | 37259170 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| T-cell dysfunction in natural killer/T-cell lymphoma. | Oncoimmunology | 2023 | 37250921 | PubTator, text mining | PubMed |
| 4H-SiC LDMOS Integrating a Trench MOS Channel Diode for Improved Reverse Recovery Performance. | Micromachines (Basel) | 2023 | 37241575 | PubTator, text mining | PubMed |
| Progress and Challenges of Immunotherapy Predictive Biomarkers for Triple Negative Breast Cancer in the Era of Single-Cell Multi-Omics. | Life (Basel) | 2023 | 37240834 | PubTator, text mining | PubMed |
| The Interplay between T Cells and Cancer: The Basis of Immunotherapy. | Genes (Basel) | 2023 | 37239368 | PubTator, text mining | PubMed |
| Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro. | Mol Biol Rep | 2023 | 37231214 | PubTator, text mining | PubMed |
| PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells. | NPJ Precis Oncol | 2023 | 37231145 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality. | J Clin Invest | 2023 | 37227784 | PubTator, text mining | PubMed |
| Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors. | Cell Rep Med | 2023 | 37224816 | PubTator, text mining | PubMed |
| A nonvolatile bidirectional reconfigurable FET based on S/D self programmable floating gates. | PLoS One | 2023 | 37224138 | PubTator, text mining | PubMed |
| CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes. | Cancer Immunol Res | 2023 | 37216576 | PubTator, text mining | PubMed |
| In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI. | Theranostics | 2023 | 37215571 | PubTator, text mining | PubMed |
Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing. | Front Oncol | 2023 | 37213285 | PubTator, text mining | PubMed |
| Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation. | Sci Adv | 2023 | 37205755 | PubTator, text mining | PubMed |
| Innate immunity and early liver inflammation. | Front Immunol | 2023 | 37205101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=26